These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15354857)

  • 1. Estrogen receptor beta dinucleotide (CA) repeat polymorphism is significantly associated with bone mineral density in postmenopausal women.
    Scariano JK; Simplicio SG; Montoya GD; Garry PJ; Baumgartner RN
    Calcif Tissue Int; 2004 Jun; 74(6):501-8. PubMed ID: 15354857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the calcitonin gene (CA) polymorphism with bone mass and bone responsiveness to hormone therapy in postmenopausal Korean women.
    Kim JG; Choi YM; Moon SY; Lee JY
    Menopause; 2003; 10(6):544-9. PubMed ID: 14627864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study.
    Tofteng CL; Kindmark A; Brändström H; Abrahamsen B; Petersen S; Stiger F; Stilgren LS; Jensen JE; Vestergaard P; Langdahl BL; Mosekilde L;
    Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis.
    Sano M; Inoue S; Hosoi T; Ouchi Y; Emi M; Shiraki M; Orimo H
    Biochem Biophys Res Commun; 1995 Dec; 217(1):378-83. PubMed ID: 8526937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
    Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between androgen receptor gene polymorphism and bone density in older women using hormone replacement therapy.
    Retornaz F; Paris F; Lumbroso S; Audran F; Tigoulet F; Michelon C; Jeandel C; Sultan C; Blain H
    Maturitas; 2006 Nov; 55(4):325-33. PubMed ID: 16759824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor gene BsmI-polymorphism in Finnish premenopausal and postmenopausal women: its association with bone mineral density, markers of bone turnover, and intestinal calcium absorption, with adjustment for lifestyle factors.
    Laaksonen M; Kärkkäinen M; Outila T; Vanninen T; Ray C; Lamberg-Allardt C
    J Bone Miner Metab; 2002; 20(6):383-90. PubMed ID: 12434167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of bone mineral density with a dinucleotide repeat polymorphism at the calcitonin (CT) locus.
    Miyao M; Hosoi T; Emi M; Nakajima T; Inoue S; Hoshino S; Shiraki M; Orimo H; Ouchi Y
    J Hum Genet; 2000; 45(6):346-50. PubMed ID: 11185743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.
    Rapuri PB; Gallagher JC; Knezetic JA; Haynatzka V
    Maturitas; 2006 Mar; 53(4):371-9. PubMed ID: 16139450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of estrogen receptor-alpha polymorphism with symptoms and other characteristics in post-menopausal women.
    Malacara JM; Pérez-Luque EL; Martínez-Garza S; Sánchez-Marín FJ
    Maturitas; 2004 Oct; 49(2):163-9. PubMed ID: 15474761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
    Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of C161-->T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-gamma gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women.
    Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
    Am J Obstet Gynecol; 2005 Apr; 192(4):1087-93. PubMed ID: 15846185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study.
    Morita A; Iki M; Dohi Y; Ikeda Y; Kagamimori S; Kagawa Y; Matsuzaki T; Yoneshima H; Marumo F;
    Int J Epidemiol; 2004 Oct; 33(5):979-88. PubMed ID: 15358739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of estrogen receptor beta gene polymorphisms with spinal bone mineral density in peri- and post-menopausal Greek women.
    Efstathiadou Z; Koukoulis G; Stakias N; Challa A; Zintzaras E; Tsatsoulis A
    Maturitas; 2006 Mar; 53(4):380-5. PubMed ID: 16125346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
    Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
    J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of estrogen receptor beta gene polymorphism with bone mineral density.
    Ogawa S; Hosoi T; Shiraki M; Orimo H; Emi M; Muramatsu M; Ouchi Y; Inoue S
    Biochem Biophys Res Commun; 2000 Mar; 269(2):537-41. PubMed ID: 10708589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the CT gene (CA) polymorphism with BMD in osteoporotic Mexican women.
    Magaña JJ; Gómez R; Cisneros B; Casas L; Castorena F; Miranda A; Diez P; Castro C; Rubio J; Valdés M
    Clin Genet; 2006 Nov; 70(5):402-8. PubMed ID: 17026622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ESR2 AluI gene polymorphism is associated with bone mineral density in postmenopausal women.
    Currò M; Marini H; Alibrandi A; Ferlazzo N; Condello S; Polito F; Adamo EB; Atteritano M; D'Anna R; Altavilla D; Bitto A; Squadrito F; Ientile R; Caccamo D
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):413-7. PubMed ID: 21689747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
    Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
    Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.